Skip to main content
SpringerLink
Log in

Bewegungstherapie bei koronarer Herzkrankheit

  • Chapter
Bewegungstherapie bei internistischen Erkrankungen

Zusammenfassung

Die koronare Herzkrankheit verursacht in den westlichen Industrieländern im Vergleich zu anderen Krankheiten die höchsten Krankheitskosten sowie die meisten Folgeerkrankungen und Todesfälle. Sie wird ganz wesentlich durch körperliche Inaktivität begünstigt, wobei weitere beeinflussbare Risikofaktoren wie Diabetes mellitus, Adipositas, arterielle Hypertonie und Rauchen zu einer gehäuften Manifestation führen. Körperliches Training bietet hier eine effektive und kostengünstige Therapieoption, die jedoch immer in Ergänzung zu anderen Therapieformen stattfinden muss.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Dietel M, Harrison TR. Harrisons Innere Medizin. Berlin; 2009.

    Google Scholar 

  2. Xanthos T, Ekmektzoglou KA, Papadimitriou L. Reviewing myocardial silent ischemia: specific patient subgroups. International journal of cardiology 2008;124(2):139–48.

    PubMed  Google Scholar 

  3. Perkutane Koronarinterventionen (PCI). Clinical Research in Cardiology 2008;97(8):513–47.

    Google Scholar 

  4. Diagnostische Herzkatheteruntersuchung. Clinical Research in Cardiology 2008;97(8):475–512.

    Google Scholar 

  5. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110(5):588–636.

    PubMed  Google Scholar 

  6. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Journal of the American College of Cardiology 2007;50(7):e1–157.

    PubMed  Google Scholar 

  7. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116(7):e148–304.

    PubMed  Google Scholar 

  8. Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. European heart journal 2008;29(23):2909–45.

    PubMed  Google Scholar 

  9. Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European heart journal 2007;28(13):1598–660.

    PubMed  CAS  Google Scholar 

  10. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation 2004;110(9):e82–293.

    PubMed  Google Scholar 

  11. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. The New England journal of medicine 2000;342(1):1–8.

    PubMed  Google Scholar 

  12. Dahlof B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359(9311):995–1003.

    PubMed  CAS  Google Scholar 

  13. Wing LM, Reid CM, Ryan P et al. A comparison of outcomes with angiotensin-converting—enzyme inhibitors and diuretics for hypertension in the elderly. The New England journal of medicine 2003;348(7):583–92.

    PubMed  CAS  Google Scholar 

  14. Major outcomes in moderately hypercholesterolemic. hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288(23):2998–3007.

    Google Scholar 

  15. Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ (Clinical researched 1998;316(7134):823–8.

    CAS  Google Scholar 

  16. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine 2003;348(5):383–93.

    PubMed  Google Scholar 

  17. Brown G, Albers JJ, Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. The New England journal of medicine 1990;323(19):1289–98.

    PubMed  CAS  Google Scholar 

  18. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282(24):2340–6.

    Google Scholar 

  19. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European heart journal 2003;24(17):1601–10.

    PubMed  Google Scholar 

  20. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486–97.

    Google Scholar 

  21. Doll R, Peto R, Wheatley K et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ (Clinical researched 1994;309(6959):901–11.

    CAS  Google Scholar 

  22. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Annals of internal medicine 1993;119(10):992–1000.

    PubMed  CAS  Google Scholar 

  23. Castelli WP, Wilson PW, Levy D et al. Cardiovascular risk factors in the elderly. The American journal of cardiology 1989;63(16):12H–9H.

    PubMed  CAS  Google Scholar 

  24. Hermanson B, Omenn GS, Kronmal RA et al. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. The New England journal of medicine 1988;319(21):1365–9.

    PubMed  CAS  Google Scholar 

  25. Gu D, Kelly TN, Wu X et al. Mortality attributable to smc-king in China. The New England journal of medicine 2009;360(2):150–9.

    PubMed  CAS  Google Scholar 

  26. Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. The New England journal of medicine 2008;359(20):2105–20.

    PubMed  CAS  Google Scholar 

  27. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. The New England journal of medicine 1999;341(6):427–34.

    PubMed  CAS  Google Scholar 

  28. Williams PT. Coronary heart disease risk factors of vigorously active sexagenarians and septuagenarians. Journal of the American Geriatrics Society 1998;46(2):134–42.

    PubMed  CAS  Google Scholar 

  29. Davies SW. Clinical presentation and diagnosis of coronary artery disease: stable angina. British medical bulletin 2001;59:17–27.

    PubMed  CAS  Google Scholar 

  30. Haskell WL, Alderman EL, Fair JM et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89(3):975–90.

    PubMed  CAS  Google Scholar 

  31. Niebauer J, Hambrecht R, Velich T et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997;96(8):2534–41.

    PubMed  CAS  Google Scholar 

  32. Schuler G, Hambrecht R, Schlierf G et al. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 1992;86(1):1–11.

    PubMed  CAS  Google Scholar 

  33. Gohlke H, Kubler W, Mathes P et al. [Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group]. Zeitschrift fur Kardiologie 2001;90(2):148–9.

    PubMed  CAS  Google Scholar 

  34. Jolliffe JA, Rees K, Taylor RS et al. Exercise-based rehabilitation for coronary heart disease. Cochrane database of systematic reviews (Online) 2001(1):CD001800.

    Google Scholar 

  35. Iestra JA, Kromhout D, van der Schouw YT et al. Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review. Circulation 2005;112(6):924–34.

    PubMed  CAS  Google Scholar 

  36. Smith SC, Jr., Allen J, Blair SN et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113(19):2363–72.

    PubMed  Google Scholar 

  37. Smith SC, Jr., Blair SN, Bonow RO et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Journal of the American College of Cardiology 2001;38(5):1581–3.

    PubMed  Google Scholar 

  38. Benzer W. Guidelines für die ambulante kardiologische Rehabilitation und Prävention in Österreich-Update 2008. Beschluss der Österreichischen Kardiologischen Gesellschaft vom Juni 2008. Journal für Kardiologie 2008(9–10):298–309.

    Google Scholar 

  39. Gohlke H, Schuler G. [Recommendations for prevention and evidence-based medicine]. Zeitschrift fur Kardiologie 2005;94 Suppl 3:III/1–5.

    Google Scholar 

  40. Dietz R, Rauch B. [Guidelines for diagnosis and treatment of chronic coronary heart disease. Issued by the executive committee of the German Society of Cardiology—Heart Circulation Research in cooperation with the German Society for Prevention and Rehabilitation of Cardiac Diseases and the German Society for Thoracic and Cardiovascular Surgery]. Zeitschrift fur Kardiologie 2003;92(6):501–21.

    PubMed  CAS  Google Scholar 

  41. Leung FP, Yung LM, Laher I et al. Exercise, vascular wall and cardiovascular diseases: an update (part 1). Sports medicine (Auckland, NZ) 2008;38(12):1009–24.

    Google Scholar 

  42. Yung LM, Laher I, Yao X et al. Exercise, vascular wall and cardiovascular diseases: an update (part 2). Sports medicine (Auckland, NZ) 2009;39(1):45–63.

    Google Scholar 

  43. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. European heart journal 1998;19(10):1434–503.

    Google Scholar 

  44. Fletcher GF, Balady GJ, Amsterdam EA et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104(14):1694–740.

    PubMed  CAS  Google Scholar 

  45. Hambrecht R, Niebauer J, Marburger C et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosderotic lesions. Journal of the American College of Cardiology 1993;22(2):468–77.

    PubMed  CAS  Google Scholar 

  46. Jakicic JM, Winters C, Lang W et al. Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweightwomen: a randomized trial. JAMA 1999;282(16):1554–60.

    PubMed  CAS  Google Scholar 

  47. Saris WH, Blair SN, van Baak MA et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 2003;4(2):101–14.

    PubMed  CAS  Google Scholar 

  48. Schoeller DA, Shay K, Kushner RF. How much physical activity is needed to minimize weight gain in previously obese women? The American journal of clinical nutrition 1997;66(3):551–6.

    PubMed  CAS  Google Scholar 

  49. Votruba SB, Horvitz MA, Schoeller DA. The role of exercise in the treatment of obesity. Nutrition (Burbank, Los Angeles County, Calif 2000;16(3):179–88.

    CAS  Google Scholar 

  50. Weinsier RL, Hunter GR, Desmond RA et al. Free-living activity energy expenditure in women successful and unsuccessful at maintaining a normal body weight. The American journal of clinical nutrition 2002;75(3):499–504.

    PubMed  CAS  Google Scholar 

  51. Wing RR, Hill JO. Successful weight loss maintenance. Annual review of nutrition 2001;21:323–41.

    PubMed  CAS  Google Scholar 

  52. Wing RR. Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Medicine and science in sports and exercise 1999;31(11 Suppl):S547–52.

    PubMed  CAS  Google Scholar 

  53. Niebauer J, Hambrecht R, Hauer K et al. Identification of patients at risk during swimming by Holter monitoring. The American journal of cardiology 1994;74(7):651–6.

    PubMed  CAS  Google Scholar 

  54. Leon AS, Franklin BA, Costa F et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2005;111(3):369–76.

    PubMed  Google Scholar 

  55. Hamar D. Resistance training for health. In: E M, ed. XXVII FIMS World Congress of Sports Medizine Budapest, June 5–9 2002:135–8.

    Google Scholar 

  56. Kelemen MH. Resistive training safety and assessment guidelines for cardiac and coronary prone patients. Medicine and science in sports and exercise 1989;21(6):675–7.

    PubMed  CAS  Google Scholar 

  57. Pollock ML, Franklin BA, Balady GJ et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation 2000;101(7):828–33.

    PubMed  CAS  Google Scholar 

  58. Sparling PB, Cantwell JD, Dolan CM et al. Strength training in a cardiac rehabilitation program: a six-month follow-up. Archives of physical medicine and rehabilitation 1990;71(2):148–52.

    PubMed  CAS  Google Scholar 

  59. Pratley R, Nicklas B, Rubin M et al. Strength training increases resting metabolic rate and norepinephrine levels in healthy 50-to 65-yr-old men. J Appl Physiol 1994;76(1):133–7.

    PubMed  CAS  Google Scholar 

  60. Wenger NK, Froelicher ES, Smith LK et al. Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. Clinical practice guideline 1995(17):1–23.

    PubMed  Google Scholar 

  61. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 1999;99(7):963–72.

    PubMed  CAS  Google Scholar 

  62. American College of Sports Medicine position stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Medicine and science in sports and exercise 1990;22(2):265–74.

    Google Scholar 

  63. Bjarnason-Wehrens B, Mayer-Berger W, Meister ER et al. Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2004;11(4):352–61.

    PubMed  CAS  Google Scholar 

  64. Bjarnason-Wehrens B, Mayer-Berger W, Meister ER et al. [The stakes of force perseverance training and musde structure training in rehabilitation. Recommendations of the German Federation for Prevention and Rehabilitation of Heart-Circulatory Disease e.v.]. Zeitschrift fur Kardiologie 2004;93(5):357–70.

    PubMed  CAS  Google Scholar 

  65. Laughlin MH. Cardiovascular response to exercise. The American journal of physiology 1999;277(6 Pt 2):S244–59.

    PubMed  CAS  Google Scholar 

  66. Sale DG, Moroz DE, McKelvie RS et al. Comparison of blood pressure response to isokinetic and weight-lifting exercise. European journal of applied physiology and occupational physiology 1993;67(2):115–20.

    PubMed  CAS  Google Scholar 

  67. Lind AR, McNicol GW. Muscular factors which determine the cardiovascular responses to sustained and rhythmic exercise. Canadian Medical Association journal 1967;96(12):706–15.

    PubMed  CAS  Google Scholar 

  68. Mitchell JH, Payne FC, Saltin B et al. The role of muscle mass in the cardiovascular response to static contractions. The Journal of physiology 1980;309:45–54.

    PubMed  CAS  Google Scholar 

  69. Niebauer J, Hambrecht R, Marburger C et al. Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. The American journal of cardiology 1995;76(11):771–5.

    PubMed  CAS  Google Scholar 

  70. Wiecek EM, McCartney N, McKelvie RS. Comparison of direct and indirect measures of systemic arterial pressure during weightlifting in coronary artery disease. The American journal of cardiology 1990;66(15):1065–9.

    PubMed  CAS  Google Scholar 

  71. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2000;35(3):838–43.

    PubMed  CAS  Google Scholar 

  72. Ehlenz H, Grosser M, Zimmermann E. Krafttraining. Grundlagen, Methoden, Übungen, Trainingsprograme. 4 ed: BLV; 1991.

    Google Scholar 

  73. Egger A, Diem G, Pirich C et al. Krafttraining als Sekundärprävention bei Diabetes mellitus Typ 2: Hypertrophie-versus Kraftausdauertraining. Österreichisches Journal für Sportmedizin 2008;38(2):29–30.

    Google Scholar 

  74. Thompson PD, Franklin BA, Balady GJ et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115(17):2358–68.

    PubMed  Google Scholar 

  75. Koplan JP, Siscovick DS, Goldbaum GM. The risks of exercise: a public health view of injuries and hazards. Public Health Rep 1985;100(2):189–95.

    PubMed  CAS  Google Scholar 

  76. Haskell WL. Cardiovascular complications during exercise training of cardiac patients. Circulation 1978;57(5):920–4.

    PubMed  CAS  Google Scholar 

  77. Van Camp SP, Peterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 1986;256(9):1160–3.

    PubMed  Google Scholar 

  78. Sorensen KE, Celermajer DS, Georgakopoulos D et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. The Journal of clinical investigation 1994;93(1):50–5.

    PubMed  CAS  Google Scholar 

  79. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis (Dallas, Tex 1989;9(1 Suppl):I19–32.

    CAS  Google Scholar 

  80. Ross R. The pathogenesis of atherosderosis: a perspective for the 1990s. Nature 1993;362(6423):801–9.

    PubMed  CAS  Google Scholar 

  81. Hambrecht R, Wolf A, Gielen S et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. The New England journal of medicine 2000;342(7):454–60.

    PubMed  CAS  Google Scholar 

  82. Ornish D, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336(8708):129–33.

    PubMed  CAS  Google Scholar 

  83. Schuler G, Hambrecht R, Schlierf G et al. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. Journal of the American College of Cardiology 1992;19(1):34–42.

    PubMed  CAS  Google Scholar 

  84. Niebauer J. Effects of exercise training on inflammatory markers in patients with heart failure. Heart Fail Rev 2008;13(1):39–49.

    PubMed  CAS  Google Scholar 

  85. Linke A, Mobius-Winkler S, Hambrecht R. [Exercise training in the treatment of coronary artery disease and obesity]. Herz 2006;31(3):224–33.

    PubMed  Google Scholar 

  86. Armstrong ML, Warner ED, Connor WE. Regression of coronary atheromatosis in rhesus monkeys. Circulation research 1970;27(1):59–67.

    PubMed  CAS  Google Scholar 

  87. Nikkila EA, Viikinkoski P, Valle M et al. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. British medical journal (Clinical researched 1984;289(6439):220–3.

    CAS  Google Scholar 

  88. Blankenhorn DH, Azen SP, Kramsch DM et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Annals of internal medicine 1993;119(10):969–76.

    PubMed  CAS  Google Scholar 

  89. Feeman WE Jr., Niebauer J. Prediction of angiographic stabilization/regression of coronary atherosclerosis by a risk factor graph. Journal of cardiovascular risk 2000;7(6):415–23.

    PubMed  Google Scholar 

  90. Frick MH, Syvanne M, Nieminen MS et al. Prevention of the angiographic progression of coronary and veingraft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. Circulation 1997;96(7):2137–43.

    PubMed  CAS  Google Scholar 

  91. Jukema JW, Bruschke AV, van Boven AJ et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995;91(10):2528–40.

    PubMed  CAS  Google Scholar 

  92. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344(8923):633–8.

    Google Scholar 

  93. Watts GF, Lewis B, Brunt JN et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS). Lancet 1992;339(8793):563–9.

    PubMed  CAS  Google Scholar 

  94. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. The New England journal of medicine 1996;335(14):1001–9.

    PubMed  CAS  Google Scholar 

  95. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934):1383–9.

    Google Scholar 

  96. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. The American journal of cardiology 2000;86(8B):3J–8J.

    PubMed  CAS  Google Scholar 

  97. Cohen MV, Yipintsoi T, Scheuer J. Coronary collateral stimulation by exercise in dogs with stenotic coronary arteries. J Appl Physiol 1982;52(3):664–71.

    PubMed  CAS  Google Scholar 

  98. Oldridge NB, Guyatt GH, Fischer ME et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988;260(7):945–50.

    PubMed  CAS  Google Scholar 

  99. O’Connor GT, Buring JE, Yusuf S et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80(2):234–44.

    PubMed  Google Scholar 

  100. Wood PD, Stefanick ML, Williams PT et al. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. The New England journal of medicine 1991;325(7):461–6.

    PubMed  CAS  Google Scholar 

  101. Katzel LI, Bleecker ER, Colman EG et al. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 1995;274(24):1915–21.

    PubMed  CAS  Google Scholar 

  102. Gottlieb SO, Jeffrey A, Brinker E et al. Effect of nifedipine on the development of coronary bypass graft stenosis in high-risk patients: a randomized, double-blind, placebo-controlled trial. Circulation 1989;80(II):228.

    Google Scholar 

  103. Lichtlen PR, Hugenholtz PG, Rafflenbeul W et al. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosderotic Therapy (INTACT). INTACT Group Investigators. Lancet 1990;335(8698):1109–13.

    PubMed  CAS  Google Scholar 

  104. Loaldi A, Polese A, Montorsi P et al. Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. The American journal of cardiology 1989;64(8):433–9.

    PubMed  CAS  Google Scholar 

  105. Waters D, Lesperance J, Francetich M et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosderosis. Circulation 1990;82(6):1940–53.

    PubMed  CAS  Google Scholar 

  106. Wang BY, Niebauer J, Singer AH et al. Felodipine inhibits intimal lesion formation in the hypercholesterolemic rabbit: differential effects on endothelial and monocyte determinants of atherogenesis. Vascular medicine (London, England) 1996;1(3):173–9.

    CAS  Google Scholar 

  107. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. The New England journal of medicine 2000;342(3):145–53.

    PubMed  CAS  Google Scholar 

  108. Lonn E, Yusuf S, Dzavik V et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103(7):919–25.

    PubMed  CAS  Google Scholar 

  109. Leon AS, Bloor CM. The effect of complete and partial deconditioning on exercise-induced cardiovascular changes in the rat. Advances in cardiology 1976;18(0):81–92.

    PubMed  CAS  Google Scholar 

  110. Stevenson JA, Feleki V, Rechnitzer P et al. Effect of Exercise on Coronary Tree Size in the Rat. Circulation research 1964;15:265–9.

    PubMed  CAS  Google Scholar 

  111. Scheel KW, Ingram LA, Wilson JL. Effects of exercise on the coronary and collateral vasculature of beagles with and without coronary occlusion. Circulation research 1981;48(4):523–30.

    PubMed  CAS  Google Scholar 

  112. Barmeyer J. Physical activity and coronary collateral development. Advances in cardiology 1976;18(0):104–12.

    PubMed  CAS  Google Scholar 

  113. Nolewajka AJ, Kostuk WJ, Rechnitzer PA et al. Exercise and human collateralization: an angiographic and scintigraphic assessment. Circulation 1979;60(1):114–21.

    PubMed  CAS  Google Scholar 

  114. Belardinelli R, Georgiou D, Ginzton L et al. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 1998;97(6):553–61.

    PubMed  CAS  Google Scholar 

  115. Ross R. Atherosclerosis—an inflammatory disease. The New England journal of medicine 1999;340(2):115–26.

    PubMed  CAS  Google Scholar 

  116. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. Journal of molecular medicine (Berlin, Germany) 1995;73(7):333–46.

    CAS  Google Scholar 

  117. Cooke JP, Stambler J, Andon N et al. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. The American journal of physiology. 1990;259(3 Pt 2):H804–12.

    PubMed  CAS  Google Scholar 

  118. Koller A, Kaley G. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circulation research 1990;67(2):529–34

    PubMed  CAS  Google Scholar 

  119. Koller A, Huang A, Sun D et al. Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circulation research 1995;76(4):544–50.

    PubMed  CAS  Google Scholar 

  120. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. The American journal of physiology 1993;264(1 Pt 2):H150–6.

    PubMed  CAS  Google Scholar 

  121. Bode-Boger SM, Boger RH, Schroder EP et al. Exercise increases systemic nitric oxide production in men. Journal of cardiovascular risk 1994;1(2):173–8.

    PubMed  CAS  Google Scholar 

  122. Maxwell AJ, Ho HV, Le CQ et al. L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. J Appl Physiol 2001;90(3):933–8.

    PubMed  CAS  Google Scholar 

  123. Maxwell AJ, Schauble E, Bernstein D et al. Limb blood flow during exercise is dependent on nitric oxide. Circulation 1998;98(4):369–74.

    PubMed  CAS  Google Scholar 

  124. Niebauer J, Maxwell AJ, Lin PS et al. Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. The American journal of physiology 1999;276(4 pt 2):H1346–54.

    PubMed  CAS  Google Scholar 

  125. Sessa WC, Pritchard K, Seyedi N et al. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circulation research 1994;74(2):349–53.

    PubMed  CAS  Google Scholar 

  126. Boger RH, Bode-Boger SM, Mugge A et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995;117(2):273–84.

    PubMed  CAS  Google Scholar 

  127. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. Journal of the American College of Cardiology 1996;28(7):1652–60.

    PubMed  CAS  Google Scholar 

  128. Tsao PS, McEvoy LM, Drexler H et al. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89(5):2176–82.

    PubMed  CAS  Google Scholar 

  129. von der Leyen HE, Gibbons GH, Morishita R et al. Gene therapy inhibiting neointimal vascular lesion in vivo transfer of endothelial cell nitric oxide synthase gene. Proceedings of the National Academy of Sciences of the United States of America 1995;92(4):1137–41.

    PubMed  Google Scholar 

  130. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth musde cells. The Journal of clinical investigation 1989;83(5):1774–7.

    PubMed  CAS  Google Scholar 

  131. Wolf A, Zalpour C, Theilmeier G et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. Journal of the American College of Cardiology 1997;29(3):479–85.

    PubMed  CAS  Google Scholar 

  132. Wang BY, Singer AH, Tsao PS et al. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. Journal of the American College of Cardiology 1994;23(2):452–8.

    PubMed  CAS  Google Scholar 

  133. Candipan RC, Wang BY, Buitrago R et al. Regression or progression. Dependency on vascular nitric oxide. Arteriosderosis, thrombosis, and vascular biology 1996;16(1):44–50.

    CAS  Google Scholar 

  134. Schwarzacher SP, Lim TT, Wang B et al. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997;95(7):1863–9.

    PubMed  CAS  Google Scholar 

  135. Niebauer J, Schwarzacher SP, Hayase M et al. Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation 1999;100(17):1830–5.

    PubMed  CAS  Google Scholar 

  136. Niebauer J, Dulak J, Chan JR et al. Gene transfer of nitric oxide synthase: effects on endothelial biology. Journal of the American College of Cardiology 1999;34(4):1201–7.

    PubMed  CAS  Google Scholar 

  137. Holtz J, Forstermann U, Pohl U et al. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. Journal of cardiovascular pharmacology 1984;6(6):1161–9.

    PubMed  CAS  Google Scholar 

  138. Berdeaux A, Ghaleh B, Dubois-Rande JL et al. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation 1994;89(6):2799–808.

    PubMed  CAS  Google Scholar 

  139. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British journal of pharmacology 1988;93(3):515–24.

    PubMed  CAS  Google Scholar 

  140. Hambrecht R, Fiehn E, Weigl C et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998;98(24):2709–15.

    PubMed  CAS  Google Scholar 

  141. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93(2):210–4.

    PubMed  CAS  Google Scholar 

  142. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101(16):1899–906.

    PubMed  CAS  Google Scholar 

  143. Kauser K, da Cunha V, Fitch R et al. Role of endogenous nitric oxide in progression of atherosderosis in apolipo-protein E-deficient mice. American journal of physiology 2000;278(5):H1679–85.

    PubMed  CAS  Google Scholar 

  144. Hornig B, Arakawa N, Kohler C et al. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97(4):363–8.

    PubMed  CAS  Google Scholar 

  145. Levine GN, Frei B, Koulouris SN et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93(6):1107–13.

    PubMed  CAS  Google Scholar 

  146. Stralin P, Karlsson K, Johansson BO et al. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arteriosderosis, thrombosis, and vascular biology 1995;15(11):2032–6.

    CAS  Google Scholar 

  147. Landmesser U, Merten R, Spiekermann S et al. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000;101(19):2264–70.

    PubMed  CAS  Google Scholar 

  148. Fukai T, Siegfried MR, Ushio-Fukai M et al. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. The Journal of dinical investigation 2000;105(11):1631–9.

    CAS  Google Scholar 

  149. Laurent S, Lacolley P, Brunel P et al. Flow-dependent vasodilation of brachial artery in essential hypertension. The American journal of physiology 1990;258(4 Pt 2):H1004–11.

    PubMed  CAS  Google Scholar 

  150. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989;79(1):93–100.

    PubMed  CAS  Google Scholar 

  151. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340(8828):1111–5.

    PubMed  CAS  Google Scholar 

  152. Sorensen KE, Celermajer DS, Spiegelhalter DJ et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. British heart journal 1995;74(3):247–53.

    PubMed  CAS  Google Scholar 

  153. Moens AL, Goovaerts I, Claeys MJ et al. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 2005;127(6):2254–63.

    PubMed  Google Scholar 

  154. Sixt S, Rastan A, Desch S et al. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. Eur J Cardiovasc Prev Rehabil 2008;15(4):473–8.

    PubMed  Google Scholar 

  155. Asahara T, Murohara T, Sullivan A et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science 1997;275(5302):964–6.

    PubMed  CAS  Google Scholar 

  156. Aicher A, Zeiher AM, Dimmeler S. Mobilizing Endothelial Progenitor Cells. Hypertension 2005;45(3):321–5.

    PubMed  CAS  Google Scholar 

  157. Takahashi T, Kalka C, Masuda H et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5(4):434–8.

    PubMed  CAS  Google Scholar 

  158. Werner N, Nickenig G. Influence of Cardiovascular Risk Factors on Endothelial Progenitor Cells: Limitations for Therary? Arterioder Thromb Vasc Biol 2006;26(2):257–66.

    CAS  Google Scholar 

  159. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. The New England journal of medicine 2005;353(10):999–1007.

    PubMed  CAS  Google Scholar 

  160. Fadini GP, Sartore S, Agostini C et al. Significance of Endothelial Progenitor Cells in Subjects With Diabetes. Diabetes Care 2007;30(5):1305–13.

    PubMed  CAS  Google Scholar 

  161. Krankel N, Adams V, Linke A et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arteriosder Thromb Vasc Biol 2005;25(4):698–703.

    Google Scholar 

  162. Niebauer J. Exercise training for the prevention and treatment of lifestyle-induced disease]. Wien Klin Wochenschr 2006;118(17–18):A30–8.

    PubMed  Google Scholar 

  163. Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109(2):220–6.

    PubMed  CAS  Google Scholar 

  164. Sandri M, Adams V, Gielen S et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005;111(25):3391–9.

    PubMed  Google Scholar 

  165. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. The New England journal of medicine 2003;348(7):593–600.

    PubMed  Google Scholar 

  166. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation research 2001;89(1):E1–7.

    PubMed  CAS  Google Scholar 

  167. Adams V, Lenk K, Linke A et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arteriosderosis, thrombosis, and vascular biology 2004;24(4):684–90.

    CAS  Google Scholar 

  168. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103(24):2885–90.

    PubMed  CAS  Google Scholar 

  169. Bahalmann FH, de Groot K, Mueller O et al. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005;45(4):526–9.

    Google Scholar 

  170. Wang CH, Verma S, Hsieh IC et al. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Journal of molecular and cellular cardiology 2006;41(1):34–43.

    PubMed  CAS  Google Scholar 

  171. Lefevre J, Michaud SE, Haddad P et al. Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide. Faseb J 2007;21(14):3845–52.

    PubMed  CAS  Google Scholar 

  172. Bowles DK. Adaptation of ion channels in the microcirculation to exercise training. Microcirculation 2000;7(1):25–40.

    PubMed  CAS  Google Scholar 

  173. Bowles DK, Woodman CR, Laughlin MH. Coronary smooth musde and endothelial adaptations to exercise training. Exercise and sport sciences reviews 2000;28(2):57–62.

    PubMed  CAS  Google Scholar 

  174. Haskell WL, Sims C, Myll J et al. Coronary artery size and dilating capacity in ultradistance runners. Circulation 1993;87(4):1076–82.

    PubMed  CAS  Google Scholar 

  175. Bowles DK, Laughlin MH, Sturek M. Exercise training alters the CA2+ and contractile responses of coronary arteries to endothelin. J Appl Physiol 1995;78(3):1079–87.

    PubMed  CAS  Google Scholar 

  176. Laher J, Zhang JH. Protein kinase C and cerebral vaso-spasm. J Cereb Blood Flow Metab 2001;78(3):887–906.

    Google Scholar 

  177. Nishizawa S, Laher I. Signaling mechanisms in cerebral vasospasm. Trends in cardiovascular medicine 2005;15(1):24–34.

    PubMed  CAS  Google Scholar 

  178. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Current medicinal chemistry 2006;13(14):1655–65.

    PubMed  CAS  Google Scholar 

  179. Symons JD, Rendig SV, Stebbins CL et al. Microvascular and myocardial contractile responses to ischemia: influence of exercise training. J Appl Physiol 2000;88(2):433–42.

    PubMed  CAS  Google Scholar 

  180. Bowles DK, Laughlin MH, Sturek M. Exercise training increases K+-channel contribution to regulation of coronary arterial tone. J Appl Physiol 1998;84(4):1225–33.

    PubMed  CAS  Google Scholar 

  181. Mokelke EA, Hu Q, Song M et al. Altered functional coupling of coronary K+ channels in diabetic dyslipidemic pigs is prevented by exercise. J Appl Physiol 2003;95(3):1179–93.

    PubMed  CAS  Google Scholar 

  182. Witcrak CA, Sturek M. Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 2004;96(3):1069–79.

    Google Scholar 

  183. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837–53.

    PubMed  Google Scholar 

  184. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (Clinical research ed 1998;317(7160):703–13.

    Google Scholar 

  185. Eliasson B. Cigarette smoking and diabetes. Progress in cardiovascular diseases 2003;45(5):405–13.

    PubMed  CAS  Google Scholar 

  186. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7–22.

    Google Scholar 

  187. Collins R, Armitage J, Parish S et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361(9374):2005–16.

    PubMed  Google Scholar 

  188. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England journal of medicine 2008;359(21):2195–207.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Sportmedizin des Landes Salzburg Paracelsus Medizinische Privatuniversität Salzburg, Universtätsinstitut für präventive und rehabilitative Sportmedizin, Lindhofstraße 20, A-5020, Salzburg

    Dr. David Niederseer & Prim. Univ.-Prof. Dr. Dr. Josef Niebauer

Authors
  1. Dr. David Niederseer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prim. Univ.-Prof. Dr. Dr. Josef Niebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Sport- und Bewegungsmedizin Fachbereich Bewegunswissenschaft Fakultät für Erziehungswissenschaft, Psychologie und Bewegungswissenschaft Universität Hamburg, Mollerstraße 10, 20148, Hamburg

    Klaus-Michael Braumann

  2. Schumannstr. 17, 40237, Düsseldorf

    Niklas Stiller

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Niederseer, D., Niebauer, J. (2010). Bewegungstherapie bei koronarer Herzkrankheit. In: Braumann, KM., Stiller, N. (eds) Bewegungstherapie bei internistischen Erkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01332-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01332-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01331-7

  • Online ISBN: 978-3-642-01332-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation